o(6)-benzylguanine has been researched along with lomeguatrib in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eichhorn, U; Hull, WE; Kaina, B; Kliem, HC; Reinhard, J; von der Lieth, CW; Wiessler, M | 1 |
Donnelly, DJ; Kelly, J; Margison, GP; McCormick, JE; McElhinney, RS; McMurry, TB; Middleton, MR; Thatcher, N | 1 |
Middleton, MR; Sabharwal, A | 1 |
1 review(s) available for o(6)-benzylguanine and lomeguatrib
Article | Year |
---|---|
Exploiting the role of O6-methylguanine-DNA-methyltransferase (MGMT) in cancer therapy.
Topics: Animals; Antineoplastic Agents; Camptothecin; Clinical Trials as Topic; Dacarbazine; DNA Adducts; DNA Methylation; DNA Topoisomerases, Type I; Drug Administration Schedule; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Guanine; Humans; Irinotecan; Neoplasms; O(6)-Methylguanine-DNA Methyltransferase; Organoplatinum Compounds; Prognosis; Promoter Regions, Genetic; Temozolomide; Topoisomerase I Inhibitors | 2006 |
2 other study(ies) available for o(6)-benzylguanine and lomeguatrib
Article | Year |
---|---|
Monosaccharide-linked inhibitors of O(6)-methylguanine-DNA methyltransferase (MGMT): synthesis, molecular modeling, and structure-activity relationships.
Topics: Cell-Free System; Crystallography, X-Ray; Enzyme Inhibitors; Glucosides; Guanine; HeLa Cells; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; Monosaccharides; O(6)-Methylguanine-DNA Methyltransferase; Solubility; Structure-Activity Relationship | 2001 |
O(6)-(4-bromothenyl)guanine improves the therapeutic index of temozolomide against A375M melanoma xenografts.
Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Synergism; Enzyme Inhibitors; Guanine; Male; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Temozolomide; Transplantation, Heterologous | 2000 |